logo for Bristol-Myers Squibb

Bristol-Myers Squibb

Manufacturing · New York, United States · 34,300 Employees

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The companys products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaboration agreements with Portola Pharmaceuticals, Inc., Apexigen, Inc., and Nordic Bioscience; clinical research collaborations with Array BioPharma, Novartis, Clovis Oncology, Inc., and Daiichi Sankyo; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York.Read More

View Company Info for Free

Who is Bristol-Myers Squibb

Bristol-Myers Squibb Headquarters

Headquarters

430 E 29th St Fl 14, New York City, New York, 10016, United States
Phone Number

Phone Number

(800) 332-2056
Bristol-Myers Squibb Revenue

Revenue

$46.2B
Stock Symbol

Stock Symbol

BMY
Industry

Industry

PharmaceuticalsHealthcareBristol-Myers Squibb's Social MediaPopular SearchesBristol-Myers SquibbBristol-myers Squibb CoCelgene CorpBristol Myers SquibbBristol - Myers Squibb CoSIC Code 28,283NAICS Code 32,325Ticker NYSE: BMYShow More

Top Competitors of Bristol-Myers Squibb

  1. Employees
    83,000
    Revenue
    $100.3B

    1

  2. Employees
    69,400
    Revenue
    $35.6B

    2

  3. Employees
    11,322
    Revenue
    $5.3B

    3

  4. Employees
    50,000
    Revenue
    $58.1B

    4

  5. Employees
    83,100
    Revenue
    $41.5B

    5

  6. Employees
    68,000
    Revenue
    $59.3B

    6

Compare CEO

How does Giovanni Caforio compare against Competing Companies' CEOs?

Giovanni Caforio

Giovanni Caforio

CEO at Bristol-Myers Squibb

Top 10%

CEO effectiveness to drive business results

Excellent
25%
Good
75%
Average
0%
Poor
0%
Very Bad
0%
CEO management style
Good
71%
Bad
28%

VS.

Joaquin Duato
Top 10%

CEO effectiveness to drive business results

Excellent
33%
Good
0%
Average
33%
Poor
16%
Very Bad
16%
CEO management style
Good
78%
Bad
21%
Select a different CEO to compare
Joaquin Duato

Joaquin Duato

CEO at Johnson & Johnson

Rob Davis

Rob Davis

CEO at Merck

Albert Bourla

Albert Bourla

CEO at Pfizer

Pascal Soriot

Pascal Soriot

CEO at AstraZeneca

Bristol-Myers Squibb Org Chart

PhonePhoneEmailEmail
David Elkins
David Elkins

Executive VP & Chief Financi...

PhonePhoneEmailEmail
Jerome Zeldis
Jerome Zeldis

Chief Executive Officer & Gl...

PhonePhoneEmailEmail

PhonePhoneEmailEmail

Bristol-Myers Squibb Email Formats

Bristol-Myers Squibb uses at least 5 email formats with first.last (ex. John.Smith@bms.com) being used 86.5% of the time

Bristol-Myers Squibb Email FormatsPercentage

Get Verified Emails

View Email Formats for Bristol-Myers Squibb

Bristol-Myers Squibb Company Metrics

Company Insights
Company Insights
Employee Growth Rate
Employee Growth Rate
Bristol-Myers Squibb Funding
Funding
Funding DateNov 06, 2020
RoundDebt
Amount$4B
InvestorsCiti, JPMorgan Chase
Funding DateMay 08, 2019
RoundDebt
Amount$19M
InvestorsUndisclosed
Funding DateFeb 23, 2017
RoundPrivate Equity
Amount-
InvestorsCarl Icahn
See More

$4B

Total Funding Amount

$4B

Most Recent Funding Amount

3

Number of Funding Rounds

Bristol-Myers Squibb Acquisitions & Subsidiaries
Acquisitions & Subsidiaries

Jul 18, 2022

Celgene

Jul 27, 2017

iZumi Bio

Jan 11, 2014

Turning Point Therapeutics

Oct 06, 2013

Mirati Therapeutics

Oct 12, 2012

MyoKardia

Mar 31, 2012

Receptos

See More Acquisitions & Subsidiaries

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Bristol-Myers Squibb News & Media

Read more news

Frequently Asked Questions regarding Bristol-Myers Squibb

Where is Bristol-Myers Squibb located?
Bristol-Myers Squibb's headquarters are located at 430 E 29th St Fl 14, New York City, New York, 10016, United States
What is Bristol-Myers Squibb's phone number?
Bristol-Myers Squibb's phone number is (800) 332-2056
What is Bristol-Myers Squibb's stock symbol?
Bristol-Myers Squibb's stock symbol is BMY
What is Bristol-Myers Squibb's official website?
Bristol-Myers Squibb's official website is www.bms.com
What is Bristol-Myers Squibb's Revenue?
Bristol-Myers Squibb's revenue is $46.2 Billion
What is Bristol-Myers Squibb's SIC code?
Bristol-Myers Squibb's SIC: 28,283
What is Bristol-Myers Squibb's NAICS code?
Bristol-Myers Squibb's NAICS: 32,325
How many employees does Bristol-Myers Squibb have?
Bristol-Myers Squibb has 34,300 employees
What industry does Bristol-Myers Squibb belong to?
Bristol-Myers Squibb is in the industry of: Pharmaceuticals, Healthcare
What is Bristol-Myers Squibb competition?
Bristol-Myers Squibb top competitors include: Pfizer Inc, GlaxoSmithKline PLC, Eisai Co. Ltd, AbbVie Inc
What companies has Bristol-Myers Squibb acquired?
Bristol-Myers Squibb has acquired the companies: Celgene, iZumi Bio, Turning Point Therapeutics, Mirati Therapeutics
Who is the CEO of Bristol-Myers Squibb?
Bristol-Myers Squibb's CEO is Jerome Zeldis
Who is the CFO of Bristol-Myers Squibb?
Bristol-Myers Squibb's CFO is Taylor Harris
How do I contact Bristol-Myers Squibb?
Bristol-Myers Squibb contact info: Phone number: (800) 332-2056 Website: www.bms.com
What does Bristol-Myers Squibb do?

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its... products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The companys products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaboration agreements with Portola Pharmaceuticals, Inc., Apexigen, Inc., and Nordic Bioscience; clinical research collaborations with Array BioPharma, Novartis, Clovis Oncology, Inc., and Daiichi Sankyo; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York.Read More

What are Bristol-Myers Squibb social media links?
Bristol-Myers Squibb Linkedin page Bristol-Myers Squibb Facebook page Bristol-Myers Squibb Twitter page
How much funding has Bristol-Myers Squibb raised to date?
Bristol-Myers Squibb has raised $4 Billion in 3 funding rounds
When was the last funding round for Bristol-Myers Squibb?
Bristol-Myers Squibb closed its last funding round on Nov 06, 2020 with the amount of $4 Billion
Who invested in Bristol-Myers Squibb?
Bristol-Myers Squibb has 4 investors including Citi, JPMorgan Chase, Undisclosed and Carl Icahn.
Is Bristol-Myers Squibb a public company?
Yes, Bristol-Myers Squibb is a public company and is traded under the symbol BMY
See more information about Bristol-Myers Squibb

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.